4/15/2010

Triple-Negative Breast Cancer: Genetic Risk and Treatment Updates

Our April teleconference explained risk factors associated with triple-negative breast cancer, as well as research and treatment options

Speakers: Rebecca Dent, MSc, MD, FRCP(C); Lisa A. Newman, MD, MPH, FACS

Download a podcast and PowerPoint presentation of the April teleconference.

Living Beyond Breast Cancer's April teleconference focused on Triple-Negative Breast Cancer: Genetic Risk and Treatment Updates. Speaker Rebecca Dent, MSc, MD, FRCP(C), of Sunnybrook Odette Cancer Centre, explored the latest research and treatment options for triple-negative breast cancer. Lisa A. Newman, MD, MPH, FACS, of the University of Michigan Comprehensive Cancer Center, discussed various risk factors associated with triple-negative breast cancer, including gene mutation, age, race and ethnicity. She also offered suggestions for how to possibly reduce your risk of recurrence by making lifestyle changes.

About Our Speakers

Dr. Dent is a nationally recognized expert in triple-negative breast cancer treatment and research. She is an assistant professor of medical oncology at the University of Toronto. Dr. Dent is the head of breast cancer clinical trials at the Sunnybrook Odette Cancer Centre in Toronto, where she serves as chair of the locally advanced breast cancer program. She also sits on the breast cancer new drug development committee for the National Cancer Institute of Canada. Dr. Dent is the principal investigator for clinical trials for the treatment of advanced breast cancer, including the role of PARP inhibitors in triple-negative breast cancer.

Dr. Lisa Newman is a professor of surgery and director of the breast care center for the University of Michigan in Ann Arbor, Michigan, where she also serves as program director for the breast fellowship. Dr. Newman holds leadership positions with the Society of Surgical Oncology and the American Society of Clinical Oncology. She serves on the breast prevention section of the National Comprehensive Cancer Network. Dr. Newman is the chief national medical advisor for the Sisters Network, Inc., a national African-American breast cancer support organization.